US0028241000
© PR Newswire
12.12.2025
ABT
LISTED
NYSE
Abbott increases quarterly dividend for 54th consecutive year
News Preview
Quarterly dividend increased by 6.8%Quarterly dividend payout has increased more than 70% since 2020408th consecutive quarterly dividend to be paid by Abbott since 1924ABBOTT PARK, Ill., Dec. 12, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its board of directors has increased the company's quarterly common dividend to 63 cents per...
Themefolio
Profiler
Peergroup
© PR Newswire
12.12.2025
ABT
LISTED
NYSE
AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs
News Preview
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Point-of-care infectious disease diagnostics valued at $53 billion in 2024 are projected to nearly double by 2033, driven by AI systems that deliver laboratory-grade results at the bedside[1]. Meanwhile, healthcare organi...
Themefolio
Profiler
Peergroup
© PR Newswire
12.12.2025
ABT
LISTED
NYSE
AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs
News Preview
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.VANCOUVER, BC, Dec. 12, 2025 /CNW/ -- USANewsGroup.com News Commentary – Point-of-care infectious disease diagnostics valued at $53 billion in 2024 are projected to nearly double by 2033, driven by AI systems that deliver laboratory-grade results at the bedside[1]. Meanwhile, healthcare organizations...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
08.12.2025
ABT
LISTED
NYSE
Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data
News Preview
Lingo, Abbott's first over-the-counter biowearable, expands to Android devicesContinuous glucose monitoring devices help people maintain healthy glucose levels, which are associated with better metabolic health and lower long-term risk of chronic conditionsNew data from Lingo users highlight how protein supplementation is linked to lower glucose i...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
07.12.2025
ABT
LISTED
NYSE
University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives
News Preview
University of Wisconsin wins Abbott and the Big Ten Conference's "We Give Blood" drive, awards $1 million from Abbott to advance student or community healthSecond year of nationwide blood drive saw a 319% increase in overall participation with 83,043 donations and a 168% jump in student donors compared to 2024Big Ten students, alumni, and fans hel...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
ABT
LISTED
NYSE
Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement
News Preview
Aging, nutrition and lifestyle affect muscles, especially after age 40. That's why Matt Ryan, former professional quarterback and MVP, is teaming up with Abbott to drive muscle health awareness with two new Ensure Max Protein shakesEnsure Max Protein 42g: For physically active adults, this new shake delivers 42 grams of complete protein to help bu...
Themefolio
Profiler
Peergroup
© PR Newswire
20.11.2025
ABT
LISTED
NYSE
Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments
News Preview
Acquisition adds a new growth vertical to Abbott's already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. cancer screening and precision oncology diagnostics segments
Acquisition will uniquely position Abbott to transform cancer care, advancing earlier...
Themefolio
Profiler
Peergroup
© PR Newswire
04.11.2025
ABT
LISTED
NYSE
Abbott HeartMates Community Delivers Holiday Cheer in Hallmark Channel's New Movie "The More the Merrier"
News Preview
Movie to feature cameos from youth who have overcome significant heart health challenges and are part of the Abbott HeartMates community as well as professional football player and HeartMates ambassador Damar Hamlin
"The More the Merrier" is the first Hallmark m...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ABT
LISTED
NYSE
Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance
News Preview
Third-quarter reported sales growth of 6.9 percent; organic sales growth of 5.5 percent or 7.5 percent excluding COVID-19 testing-related sales1
Third-quarter GAAP diluted EPS of $0.94; adjusted diluted EPS of $1.30...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ABT
LISTED
NYSE
Abbott's Dissolving Stent Receives Health Canada Approval for Treating Blocked Arteries Below-the-Knee
News Preview
More than 800,000 Canadians1 live with peripheral artery disease (PAD) with limited treatment options to date1
The first-of-its-kind dissolvable stent, the Esprit™ BTK Everolimus Eluting Resorbable Scaffold, dissolves over time after it has opened blocked arteries below-the-knee (BTK)...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
ABT
LISTED
NYSE
Abbott Hosts Conference Call for Third-Quarter Earnings
News Preview
ABBOTT PARK, Ill., Sept. 24, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens.
The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor R...
Themefolio
Profiler
Peergroup
© PR Newswire
19.09.2025
ABT
LISTED
NYSE
Abbott Declares 407th Consecutive Quarterly Dividend
News Preview
ABBOTT PARK, Ill., Sept. 19, 2025 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share.
This marks the 407th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov. 17, 2025, to shareholders of record at the close of business on Oct...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
29.08.2025
ABT
LISTED
NYSE
Abbott's Navitor™ TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis
News Preview
Navitor is now approved as a minimally invasive alternative to surgery for patients in Europe with symptomatic, severe aortic stenosis (a common and life-threatening heart valve disease) who are at low or intermediate surgical riskCE Mark is based on safety and effectiveness data from the VANTAGE trial presented at the European Society of Cardi...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ABT
LISTED
NYSE
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment
News Preview
Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for millions of ThaisThis approval builds on Abbott's biosimilar portfolio in Asia Pacific, following recent launches in Malaysia and IndiaBANGKOK, Aug. 26, 2025 /PRNewswire/ -- Abbott (NYSE: ABT),...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ABT
LISTED
NYSE
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment
News Preview
Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for millions of ThaisThis approval builds on Abbott's biosimilar portfolio in Asia Pacific, following recent launches in Malaysia and IndiaBANGKOK, Aug. 26, 2025 /PRNewswire/ -- Abbott (NYSE: ABT),...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ABT
LISTED
NYSE
Abbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season
News Preview
All 18 Big Ten universities will go head-to-head in Year 2 of the nationwide challenge, the 'We Give Blood' drive, to inspire the most blood donations from students, alumni, and fans with the winning school earning $1 million from Abbott for student or community healthAbbott is releasing exclusive, limited-edition Homefield designed T-shirts fo...
Themefolio
Profiler
Peergroup
© PR Newswire
17.07.2025
ABT
LISTED
NYSE
Abbott Reports Second-Quarter 2025 Results
News Preview
Second-quarter reported sales growth of 7.4 percent; organic sales growth of 6.9 percent or 7.5 percent excluding COVID-19 testing-related sales1Second-quarter GAAP diluted EPS of $1.01; adjusted diluted EPS of $1.26Reported gross margin of 52.7 percent of sales; adjusted gross margin of 57.0 percent, which reflects a 100 basis point increaseRepo...
Themefolio
Profiler
Peergroup
© PR Newswire
15.07.2025
ABT
LISTED
NYSE
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
News Preview
MarketNewsUpdates News Commentary
NEW YORK, July 15, 2025 /PRNewswire/ -- Artificial Intelligence (AI) algorithms are revolutionizing the way retina images are analyzed for detecting conditions such as age-related macular degeneration (AMD) and diabetic retinopathy. These advanced algorithms often achieve diagnostic accuracies that equal or surpa...
Themefolio
Profiler
Peergroup
© PR Newswire
15.07.2025
ABT
LISTED
NYSE
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
News Preview
MarketNewsUpdates News Commentary
NEW YORK, July 15, 2025 /CNW/ -- Artificial Intelligence (AI) algorithms are revolutionizing the way retina images are analyzed for detecting conditions such as age-related macular degeneration (AMD) and diabetic retinopathy. These advanced algorithms often achieve diagnostic accuracies that equal or surpass huma...
Themefolio
Profiler
Peergroup
© PR Newswire
15.07.2025
ABT
LISTED
NYSE
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
News Preview
MarketNewsUpdates News Commentary
NEW YORK, July 15, 2025 /PRNewswire/ -- Artificial Intelligence (AI) algorithms are revolutionizing the way retina images are analyzed for detecting conditions such as age-related macular degeneration (AMD) and diabetic retinopathy. These advanced algorithms often achieve diagnostic accuracies that equal or surpa...
Themefolio
Profiler
Peergroup
© PR Newswire
08.07.2025
ABT
LISTED
NYSE
Abbott's Latest-Generation FreeStyle Libre 3 Plus Glucose Sensor Technology Launches in Canada
News Preview
Abbott continues to transform diabetes care with its leading Libre systems and the new FreeStyle Libre 3 Plus* sensor MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus* sensor, is now available to Canadians living with diab...
Themefolio
Profiler
Peergroup
© PR Newswire
08.07.2025
ABT
LISTED
NYSE
Abbott's Latest-Generation FreeStyle Libre 3 Plus Glucose Sensor Technology Launches in Canada
News Preview
Abbott continues to transform diabetes care with its leading Libre systems and the new FreeStyle Libre 3 Plus* sensor MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus* sensor, is now available to Canadians living with diab...
Themefolio
Profiler
Peergroup
© PR Newswire
26.06.2025
ABT
LISTED
NYSE
Abbott Hosts Conference Call for Second-Quarter Earnings
News Preview
ABBOTT PARK, Ill., June 26, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2025 financial results on Thursday, July 17, before the market opens.
The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor Re...
Themefolio
Profiler
Peergroup
© PR Newswire
21.06.2025
ABT
LISTED
NYSE
New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier
News Preview
Randomized, controlled clinical trial presented as a late-breaking poster at ADA's Scientific Sessions shows people participating in Abbott's Healthy Food Rx ate more vegetables and fruit, and reported significantly improved health status.Abbott's Healthy Food Rx community-focused "food is medicine" program provides home-delivered healthy food bo...
Themefolio
Profiler
Peergroup
© PR Newswire
16.06.2025
ABT
LISTED
NYSE
Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions
News Preview
The test, run on Abbott's portable i-STAT® Alinity® instrument, uses whole blood to help evaluate patients with a suspected mild traumatic brain injury (mTBI), otherwise known as concussionThe test produces lab-quality results in 15 minutesClinicians can get a result at the patient's bedside, making the test accessible at urgent care clinics and...
Themefolio
Profiler
Peergroup
© PR Newswire
13.06.2025
ABT
LISTED
NYSE
Abbott Declares 406th Consecutive Quarterly Dividend
News Preview
ABBOTT PARK, Ill., June 13, 2025 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share.
This marks the 406th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 15, 2025, to shareholders of record at the close of business on July...
Themefolio
Profiler
Peergroup
© PR Newswire
27.05.2025
ABT
LISTED
NYSE
Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery
News Preview
The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC)Tendyne offers a new treatment option for patients who are not candidates for open-heart surgery or mitral repairThis approval expands Abbott's portfolio of minimally...
Themefolio
Profiler
Peergroup
© PR Newswire
15.05.2025
ABT
LISTED
NYSE
Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes
News Preview
New data reveal a 78% reduction in cardiovascular disease-related hospitalizations for people living with Type 1 diabetes with prior severe low blood sugar episodes.1This significant decrease is linked to the use of Libre biowearable technology compared to traditional blood glucose monitors.1Results also show a reduction in hospitalization for ca...
Themefolio
Profiler
Peergroup
© PR Newswire
07.05.2025
ABT
LISTED
NYSE
Abbott and Real Madrid Kick Off Search to Empower Young Soccer Talent
News Preview
This summer, Abbott and Real Madrid are hosting tryouts across the U.S. to form the 'Abbott Dream Team'Tryout attendees will learn about health and sports nutrition, encouraging them to promote healthy habits and an active lifestyle in their communitiesEleven selected players will travel to Madrid, train at Real Madrid's world-class facilities, a...
Themefolio
Profiler
Peergroup
© PR Newswire
01.05.2025
ABT
LISTED
NYSE
MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races
News Preview
The test, run on Abbott's portable i-STAT® Alinity® hand-held instrument, uses whole blood to help evaluate patients 18 years of age and older with a suspected mild traumatic brain injury, or concussion, producing lab-quality results in 15 minutesThe test will be used by healthcare professionals in the medical facilities at all MotoAmerica races...
Themefolio
Profiler
Peergroup
© PR Newswire
29.04.2025
ABT
LISTED
NYSE
Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information
News Preview
Collaboration brings together FreeStyle Libre® Systems, the world's leading continuous glucose monitoring technology (CGM)1 with Epic, a healthcare software company, to streamline access to CGM data for healthcare organizationsIntegration empowers U.S. clinicians to enhance patient care by incorporating Libre's data directly into their workflowsA...
Themefolio
Profiler
Peergroup
© PR Newswire
27.04.2025
ABT
LISTED
NYSE
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
News Preview
Late-breaking data from Abbott's groundbreaking first-in-human study demonstrated successful implantation of the company's AVEIR Conduction System Pacing (CSP) leadless pacemaker
Enrollment has also begun in the ASCEND CSP pivotal clinical trial to evaluate Abbott's investigational CSP Implantable Cardioverter-Defibrillator (ICD) lead
Conductio...
Themefolio
Profiler
Peergroup
© PR Newswire
27.04.2025
ABT
LISTED
NYSE
New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib
News Preview
Long-term data from the Volt CE Mark Study show strong results out to 12 months in patients receiving pulsed field ablation (PFA) therapy with the Volt™ PFA SystemThe 12-month results of the Volt CE Mark Study confirm the long-term safety and efficacy of the Volt PFA SystemThe data were presented at the 2025 Heart Rhythm Society (HRS) annual meet...
Themefolio
Profiler
Peergroup
© PR Newswire
27.04.2025
ABT
LISTED
NYSE
New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib
News Preview
Long-term data from the Volt CE Mark Study show strong results out to 12 months in patients receiving pulsed field ablation (PFA) therapy with the Volt™ PFA SystemThe 12-month results of the Volt CE Mark Study confirm the long-term safety and efficacy of the Volt PFA SystemThe data were presented at the 2025 Heart Rhythm Society (HRS) annual meet...
Themefolio
Profiler
Peergroup
© PR Newswire
16.04.2025
ABT
LISTED
NYSE
Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance
News Preview
First-quarter GAAP diluted EPS of $0.76; adjusted diluted EPS of $1.09First-quarter reported sales growth of 4.0 percent; organic sales growth of 6.9 percent or 8.3 percent when excluding COVID-19 testing-related sales1Reported gross margin of 52.8 percent of sales; adjusted gross margin of 57.1 percent, which reflects a 140 basis point increaseR...
Themefolio
Profiler
Peergroup
© PR Newswire
31.03.2025
ABT
LISTED
NYSE
New Late-Breaking Data Reinforce Benefits of Abbott's TriClip™ for People With Leaky Tricuspid Heart Valve
News Preview
TRILUMINATE™ Pivotal data presented at the American College of Cardiology's Annual Scientific Session (ACC.25) and simultaneously published in Circulation show the Abbott TriClip system reduces heart failure hospitalizationsThe latest results highlight significant improvements in tricuspid regurgitation and quality of life through two yearsABBOTT...
Themefolio
Profiler
Peergroup
© PR Newswire
27.03.2025
ABT
LISTED
NYSE
Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
News Preview
Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillationPulsed field ablation – or PFA – uses high energy electrical pulses for ablation procedures that may offer benefits to targeting and treating tissue in the heartAbbott's Volt PFA System is designed to overcom...
Themefolio
Profiler
Peergroup
© PR Newswire
27.03.2025
ABT
LISTED
NYSE
Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
News Preview
Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillationPulsed field ablation – or PFA – uses high energy electrical pulses for ablation procedures that may offer benefits to targeting and treating tissue in the heartAbbott's Volt PFA System is designed to overcom...
Themefolio
Profiler
Peergroup
© PR Newswire
26.03.2025
ABT
LISTED
NYSE
Abbott Hosts Conference Call for First-Quarter Earnings
News Preview
ABBOTT PARK, Ill., March 26, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its first-quarter 2025 financial results on Wednesday, April 16, before the market opens.
The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor...
Themefolio
Profiler
Peergroup
© PR Newswire
24.03.2025
ABT
LISTED
NYSE
Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease
News Preview
Coronary Artery Disease (CAD) is the most common heart disease and most frequent cause of death in the U.S., with over 20 million adults affected by this conditionAbbott's investigational Coronary Intravascular Lithotripsy (IVL) System offers a new potential treatment by using sound pressure waves to treat arterial calcium blockagesAbbott offers...
Themefolio
Profiler
Peergroup
© PR Newswire
21.02.2025
ABT
LISTED
NYSE
Abbott Declares 405th Consecutive Quarterly Dividend
News Preview
ABBOTT PARK, Ill., Feb. 21, 2025 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share.
This marks the 405th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable May 15, 2025, to shareholders of record at the close of business on April...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2025
ABT
LISTED
NYSE
Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care
News Preview
New survey shows 40% of people living with diabetes have skipped or missed a doctor's appointment due to shame or stigma170% of people with diabetes said supportive comments from others can significantly boost their motivation to manage their condition1Abbott launches film that highlights challenges of living life with diabetesABBOTT PARK, Ill.,...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2025
ABT
LISTED
NYSE
Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care
News Preview
New survey shows 40 per cent of people living with diabetes have skipped or missed a doctor's appointment due to shame or stigma170 per cent of people living with diabetes said supportive comments from others can significantly boost their motivation to manage their condition1Abbott launches film that highlights challenges of living life with diab...
Themefolio
Profiler
Peergroup
© PR Newswire
22.01.2025
ABT
LISTED
NYSE
Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook
News Preview
Fourth-quarter sales of $11.0 billion; full-year 2024 sales of $42.0 billionFourth-quarter reported sales increased 7.2 percent; organic sales growth for the underlying base business increased 10.1 percent1Full-year 2024 reported sales increased 4.6 percent; organic sales growth for the underlying base business increased 9.6 percent2Abbott projec...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2025
ABT
LISTED
NYSE
Abbott Hosts Conference Call for Fourth-Quarter Earnings
News Preview
ABBOTT PARK, Ill., Jan. 2, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its fourth-quarter 2024 financial results on Wednesday, Jan. 22, before the market opens.
The announcement will be followed by a live webcast of the earnings conference call at 8:30 a.m. Central time (9:30 a.m. Eastern) and will be accessible through Abbott's Inves...
Themefolio
Profiler
Peergroup
© PR Newswire
17.12.2024
ABT
LISTED
NYSE
Abbott's FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in Alberta
News Preview
MISSISSAUGA, ON, Dec. 17, 2024 /CNW/ -- Abbott (NYSE: ABT) today announced that the Government of Alberta has added Abbott's FreeStyle Libre 2* flash glucose monitoring system to the Alberta Drug Benefit List.
Starting December 16, 2024, Alberta residents living with diabetes can access provincial reimbursement of the FreeStyle Libre 2 system if...
Themefolio
Profiler
Peergroup
© PR Newswire
17.12.2024
ABT
LISTED
NYSE
Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart
News Preview
Abbott's investigational AVEIR™ Conduction System Pacing (CSP) leadless pacemaker system is specifically designed to deliver pacing to the left bundle branch area, activating the heart's natural conduction systemThe device has received U.S. Food and Drug Administration Breakthrough Device Designation, which expedites the review of innovative tech...
Themefolio
Profiler
Peergroup
© PR Newswire
13.12.2024
ABT
LISTED
NYSE
Abbott Increases Quarterly Dividend for 53rd Consecutive Year
News Preview
Dividend increased by 7.3%Quarterly dividend payout has increased more than 60% since 2020404th consecutive quarterly dividend to be paid by Abbott since 1924ABBOTT PARK, Ill., Dec. 13, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its board of directors has increased the company's quarterly common dividend to 59 cents per share, a...
Themefolio
Profiler
Peergroup
© PR Newswire
08.12.2024
ABT
LISTED
NYSE
University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott
News Preview
Nearly 20,000 Big Ten students, alumni and fans across the country donated blood as part of the Abbott-Big Ten nationwide competition this college football season, helping save as many as 60,000 livesNebraska's win was announced at the Discover Big Ten Football Championship Game where the university received $1 million from global healthcare comp...
Themefolio
Profiler
Peergroup
© PR Newswire
25.11.2024
ABT
LISTED
NYSE
Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis
News Preview
The investigational transcatheter aortic valve implantation (TAVI) system will complement Abbott's Navitor™ TAVI system for aortic stenosis, a common and life-threatening heart valve diseaseThe investigational system is designed to offer best-in-class heart blood flow, ease of use and precisionApproximately 9% of older Americans have aortic steno...
Themefolio
Profiler
Peergroup
© PR Newswire
18.11.2024
ABT
LISTED
NYSE
Abbott eröffnet eine hochmoderne globale Produktionsstätte in Kilkenny, Irland
News Preview
An Taoiseach, Simon Harris, TD, und Robert Ford, Chairman und Chief Executive Officer von Abbott, nehmen an der offiziellen Eröffnung teilÜber 800 Mitarbeiter sollen in der Produktionsstätte für Diabetes-Technologie beschäftigt werden, die Teil einer 440-Millionen-Euro-Investition ist, die Abbott an zwei Standorten in Irland tätigt.Die Anlage wir...
Themefolio
Profiler
Peergroup
© PR Newswire
18.11.2024
ABT
LISTED
NYSE
Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland
News Preview
An Taoiseach, Simon Harris, TD, and Abbott Chairman and Chief Executive Officer, Robert Ford, attend official openingOver 800 to be employed at the diabetes technology manufacturing site, which is part of a €440 million investment Abbott is making across two sites in IrelandFacility will have the highest production of FreeStyle Libre® sensors in...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2024
ABT
LISTED
NYSE
New Canadian Report Shows Positivity Instead of Criticism is Key in Diabetes Management
News Preview
Canadians living with type 2 diabetes agree that uplifting words, positive feedback and supportive tools are the most powerful motivatorsMISSISSAUGA, ON, Oct. 30, 2024 /CNW/ -- Abbott (NYSE: ABT) today released new data highlighting the emotional challenges faced by people living with type 2 diabetes, revealing key motivators to help them manage...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2024
ABT
LISTED
NYSE
Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure
News Preview
The first-of-its-kind TEAM-HF study seeks to improve clinical outcomes in patients with worsening heart failureTrial establishes new, objective criteria to identify patients most at risk for developing end-stage heart failure and potentially offer life-saving therapeutic options sooner in their disease progressionABBOTT PARK, Ill., Oct. 24, 2024...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2024
ABT
LISTED
NYSE
Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance Range
News Preview
Sales of $10.6 billion driven by strong underlying base business performance Reported sales growth of 4.9 percent; organic sales growth for underlying base business of 8.2 percent1, led by double-digit growth in Medical DevicesContinues to strengthen portfolio with steady cadence of new product approvals, reimbursement coverage, and clinical data...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2024
ABT
LISTED
NYSE
Abbott Advances Pulsed Field Ablation Clinical Studies and Launches New Technology to Support Advanced Cardiac Mapping
News Preview
Enrollment completed ahead of schedule in the global IDE for Abbott's Volt™ PFA SystemGlobal FOCALFLEX trial now underway for Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™Advisor™ HD Grid X Mapping Catheter, Sensor Enabled™, receives U.S. Food and Drug Administration clearance, begins commercial launchABBOTT PARK, Ill., Oct. 10, 2024...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2024
ABT
LISTED
NYSE
Abbott and the Big Ten Conference Tackle U.S. Blood Shortages with First-of-its-Kind, Nationwide Blood Donation Competition, 'The We Give Blood Drive'
News Preview
To help address the greatest need for blood in a generation, Abbott, a global leader in blood testing, and the Big Ten Conference are teaming up to host the first college conference-wide blood donation competitionThe school that drives the most blood donations during the 2024 football season will be honored by Abbott at the Discover Big Ten Footb...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2024
ABT
LISTED
NYSE
Abbott Hosts Conference Call for Third-Quarter Earnings
News Preview
ABBOTT PARK, Ill., Sept. 25, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2024 financial results on Wednesday, Oct. 16, before the market opens.
The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor R...
Themefolio
Profiler
Peergroup
© PR Newswire
19.09.2024
ABT
LISTED
NYSE
Abbott Declares 403rd Consecutive Quarterly Dividend
News Preview
ABBOTT PARK, Ill., Sept. 19, 2024 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 55 cents per share.
This marks the 403rd consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov. 15, 2024, to shareholders of record at the close of business on Oct...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2024
ABT
LISTED
NYSE
Abbott's Lingo™ Continuous Glucose Monitor for Health and Wellness Now Available in the U.S.
News Preview
Designed for people interested in improving their overall health and wellnessProvides real-time glucose data and personal coaching insights based on the body's reaction to nutrition, exercise and life's daily stressorsAvailable without a prescription; explore different purchase options at www.hellolingo.com ABBOTT PARK, Ill., Sept. 5, 2024 /PRNe...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
